nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GRIA3—nerve—acquired immunodeficiency syndrome	0.0334	0.0987	CbGeAlD
Lithium—GSK3B—nerve—acquired immunodeficiency syndrome	0.029	0.0855	CbGeAlD
Lithium—IMPA1—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.0118	0.0882	CbGpPWpGaD
Lithium—IMPA1—lymphoid tissue—acquired immunodeficiency syndrome	0.0116	0.0342	CbGeAlD
Lithium—IMPA1—blood—acquired immunodeficiency syndrome	0.0109	0.0322	CbGeAlD
Lithium—IMPA2—skin of body—acquired immunodeficiency syndrome	0.0107	0.0317	CbGeAlD
Lithium—GSK3A—retina—acquired immunodeficiency syndrome	0.0104	0.0308	CbGeAlD
Lithium—GRIA3—spinal cord—acquired immunodeficiency syndrome	0.00893	0.0264	CbGeAlD
Lithium—IMPA1—nervous system—acquired immunodeficiency syndrome	0.00884	0.0261	CbGeAlD
Lithium—IMPA2—digestive system—acquired immunodeficiency syndrome	0.00858	0.0253	CbGeAlD
Lithium—GSK3B—lymphoid tissue—acquired immunodeficiency syndrome	0.00852	0.0252	CbGeAlD
Lithium—IMPA1—central nervous system—acquired immunodeficiency syndrome	0.00852	0.0251	CbGeAlD
Lithium—GSK3B—digestive system—acquired immunodeficiency syndrome	0.00842	0.0249	CbGeAlD
Lithium—IMPA2—blood—acquired immunodeficiency syndrome	0.00818	0.0241	CbGeAlD
Lithium—GSK3B—blood—acquired immunodeficiency syndrome	0.00802	0.0237	CbGeAlD
Lithium—IMPA2—bone marrow—acquired immunodeficiency syndrome	0.00791	0.0234	CbGeAlD
Lithium—GSK3B—spinal cord—acquired immunodeficiency syndrome	0.00773	0.0228	CbGeAlD
Lithium—IMPA2—vagina—acquired immunodeficiency syndrome	0.00758	0.0224	CbGeAlD
Lithium—GRIA3—nervous system—acquired immunodeficiency syndrome	0.00752	0.0222	CbGeAlD
Lithium—GSK3B—vagina—acquired immunodeficiency syndrome	0.00744	0.022	CbGeAlD
Lithium—GSK3A—digestive system—acquired immunodeficiency syndrome	0.00732	0.0216	CbGeAlD
Lithium—GRIA3—central nervous system—acquired immunodeficiency syndrome	0.00724	0.0214	CbGeAlD
Lithium—IMPA2—lung—acquired immunodeficiency syndrome	0.00717	0.0212	CbGeAlD
Lithium—GSK3B—lung—acquired immunodeficiency syndrome	0.00703	0.0208	CbGeAlD
Lithium—GSK3A—blood—acquired immunodeficiency syndrome	0.00697	0.0206	CbGeAlD
Lithium—IMPA1—brain—acquired immunodeficiency syndrome	0.00676	0.02	CbGeAlD
Lithium—GSK3A—bone marrow—acquired immunodeficiency syndrome	0.00675	0.0199	CbGeAlD
Lithium—GSK3A—spinal cord—acquired immunodeficiency syndrome	0.00672	0.0198	CbGeAlD
Lithium—GSK3B—nervous system—acquired immunodeficiency syndrome	0.00651	0.0192	CbGeAlD
Lithium—GSK3A—vagina—acquired immunodeficiency syndrome	0.00647	0.0191	CbGeAlD
Lithium—GSK3B—central nervous system—acquired immunodeficiency syndrome	0.00627	0.0185	CbGeAlD
Lithium—GSK3A—lung—acquired immunodeficiency syndrome	0.00611	0.0181	CbGeAlD
Lithium—GRIA3—brain—acquired immunodeficiency syndrome	0.00575	0.017	CbGeAlD
Lithium—GSK3A—nervous system—acquired immunodeficiency syndrome	0.00566	0.0167	CbGeAlD
Lithium—GSK3A—T-Cell Receptor and Co-stimulatory Signaling—CD8A—acquired immunodeficiency syndrome	0.00556	0.0416	CbGpPWpGaD
Lithium—GSK3A—central nervous system—acquired immunodeficiency syndrome	0.00545	0.0161	CbGeAlD
Lithium—IMPA2—brain—acquired immunodeficiency syndrome	0.00507	0.015	CbGeAlD
Lithium—GSK3B—brain—acquired immunodeficiency syndrome	0.00498	0.0147	CbGeAlD
Lithium—IMPA2—lymph node—acquired immunodeficiency syndrome	0.0049	0.0145	CbGeAlD
Lithium—GSK3B—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00483	0.0361	CbGpPWpGaD
Lithium—GSK3B—lymph node—acquired immunodeficiency syndrome	0.00481	0.0142	CbGeAlD
Lithium—GSK3A—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.00444	0.0332	CbGpPWpGaD
Lithium—GSK3A—brain—acquired immunodeficiency syndrome	0.00433	0.0128	CbGeAlD
Lithium—GSK3A—lymph node—acquired immunodeficiency syndrome	0.00418	0.0123	CbGeAlD
Lithium—GSK3B—T-Cell Receptor and Co-stimulatory Signaling—CD8A—acquired immunodeficiency syndrome	0.00411	0.0307	CbGpPWpGaD
Lithium—GSK3B—Cardiac Progenitor Differentiation—CXCR4—acquired immunodeficiency syndrome	0.00338	0.0253	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.0031	0.0232	CbGpPWpGaD
Lithium—GSK3A—T-Cell Receptor and Co-stimulatory Signaling—IL2—acquired immunodeficiency syndrome	0.00294	0.022	CbGpPWpGaD
Lithium—GSK3A—B Cell Receptor Signaling Pathway—CD79A—acquired immunodeficiency syndrome	0.00262	0.0196	CbGpPWpGaD
Lithium—IMPA2—Metabolism—TAT—acquired immunodeficiency syndrome	0.00255	0.0191	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.00246	0.0184	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—CCL3—acquired immunodeficiency syndrome	0.0023	0.0172	CbGpPWpGaD
Lithium—IMPA1—Metabolism—TAT—acquired immunodeficiency syndrome	0.00227	0.017	CbGpPWpGaD
Lithium—GSK3A—IL-5 Signaling Pathway—IL2—acquired immunodeficiency syndrome	0.00227	0.017	CbGpPWpGaD
Lithium—GSK3B—T-Cell Receptor and Co-stimulatory Signaling—IL2—acquired immunodeficiency syndrome	0.00217	0.0162	CbGpPWpGaD
Lithium—IMPA2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00217	0.0162	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—ACTG1—acquired immunodeficiency syndrome	0.00201	0.015	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.00197	0.0147	CbGpPWpGaD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—CD79A—acquired immunodeficiency syndrome	0.00194	0.0145	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00193	0.0145	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	0.00179	0.0134	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	0.00176	0.0132	CbGpPWpGaD
Lithium—GSK3B—IL-5 Signaling Pathway—IL2—acquired immunodeficiency syndrome	0.00168	0.0126	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.0015	0.0112	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.00146	0.0109	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.00131	0.00982	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.00126	0.00941	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.00118	0.0088	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.00112	0.00837	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.00111	0.0083	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	0.00106	0.00796	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000948	0.0071	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000947	0.00709	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	0.000945	0.00707	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000936	0.00701	CbGpPWpGaD
Lithium—GSK3B—IL-6 signaling pathway—IL6—acquired immunodeficiency syndrome	0.000931	0.00697	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.000929	0.00696	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000919	0.00688	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IFNG—acquired immunodeficiency syndrome	0.000872	0.00653	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	0.000862	0.00645	CbGpPWpGaD
Lithium—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000841	0.00159	CcSEcCtD
Lithium—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000839	0.00159	CcSEcCtD
Lithium—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000838	0.00159	CcSEcCtD
Lithium—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000837	0.00159	CcSEcCtD
Lithium—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000835	0.00158	CcSEcCtD
Lithium—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000833	0.00158	CcSEcCtD
Lithium—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000833	0.00158	CcSEcCtD
Lithium—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000833	0.00158	CcSEcCtD
Lithium—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000832	0.00158	CcSEcCtD
Lithium—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.00083	0.00157	CcSEcCtD
Lithium—GSK3B—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000827	0.00619	CbGpPWpGaD
Lithium—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000826	0.00157	CcSEcCtD
Lithium—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000825	0.00156	CcSEcCtD
Lithium—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000825	0.00156	CcSEcCtD
Lithium—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000823	0.00156	CcSEcCtD
Lithium—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000823	0.00156	CcSEcCtD
Lithium—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00082	0.00155	CcSEcCtD
Lithium—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000819	0.00155	CcSEcCtD
Lithium—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000818	0.00155	CcSEcCtD
Lithium—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000817	0.00155	CcSEcCtD
Lithium—GSK3A—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000816	0.00611	CbGpPWpGaD
Lithium—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000811	0.00154	CcSEcCtD
Lithium—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000811	0.00154	CcSEcCtD
Lithium—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00081	0.00154	CcSEcCtD
Lithium—Shock—Indinavir—acquired immunodeficiency syndrome	0.000809	0.00153	CcSEcCtD
Lithium—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000807	0.00153	CcSEcCtD
Lithium—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000807	0.00153	CcSEcCtD
Lithium—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000806	0.00153	CcSEcCtD
Lithium—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000806	0.00153	CcSEcCtD
Lithium—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000805	0.00152	CcSEcCtD
Lithium—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000805	0.00152	CcSEcCtD
Lithium—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000802	0.00152	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000802	0.006	CbGpPWpGaD
Lithium—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000801	0.00152	CcSEcCtD
Lithium—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000801	0.00152	CcSEcCtD
Lithium—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000799	0.00151	CcSEcCtD
Lithium—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000794	0.00151	CcSEcCtD
Lithium—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000794	0.00151	CcSEcCtD
Lithium—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000793	0.0015	CcSEcCtD
Lithium—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000793	0.0015	CcSEcCtD
Lithium—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000793	0.0015	CcSEcCtD
Lithium—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00079	0.0015	CcSEcCtD
Lithium—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000787	0.00149	CcSEcCtD
Lithium—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000786	0.00149	CcSEcCtD
Lithium—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000784	0.00149	CcSEcCtD
Lithium—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000784	0.00149	CcSEcCtD
Lithium—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000779	0.00148	CcSEcCtD
Lithium—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000776	0.00147	CcSEcCtD
Lithium—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000774	0.00147	CcSEcCtD
Lithium—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000769	0.00146	CcSEcCtD
Lithium—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000767	0.00145	CcSEcCtD
Lithium—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000765	0.00145	CcSEcCtD
Lithium—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000764	0.00145	CcSEcCtD
Lithium—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000763	0.00145	CcSEcCtD
Lithium—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000763	0.00144	CcSEcCtD
Lithium—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00076	0.00144	CcSEcCtD
Lithium—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000759	0.00144	CcSEcCtD
Lithium—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000758	0.00144	CcSEcCtD
Lithium—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000757	0.00143	CcSEcCtD
Lithium—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000756	0.00143	CcSEcCtD
Lithium—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000756	0.00143	CcSEcCtD
Lithium—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00075	0.00142	CcSEcCtD
Lithium—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00075	0.00142	CcSEcCtD
Lithium—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000745	0.00141	CcSEcCtD
Lithium—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000745	0.00141	CcSEcCtD
Lithium—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000744	0.00141	CcSEcCtD
Lithium—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000741	0.0014	CcSEcCtD
Lithium—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000741	0.0014	CcSEcCtD
Lithium—Rash—Didanosine—acquired immunodeficiency syndrome	0.000739	0.0014	CcSEcCtD
Lithium—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000739	0.0014	CcSEcCtD
Lithium—Headache—Didanosine—acquired immunodeficiency syndrome	0.000734	0.00139	CcSEcCtD
Lithium—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000733	0.00139	CcSEcCtD
Lithium—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000732	0.00139	CcSEcCtD
Lithium—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000731	0.00139	CcSEcCtD
Lithium—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00073	0.00138	CcSEcCtD
Lithium—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00073	0.00138	CcSEcCtD
Lithium—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000729	0.00138	CcSEcCtD
Lithium—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000729	0.00138	CcSEcCtD
Lithium—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000727	0.00138	CcSEcCtD
Lithium—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000725	0.00137	CcSEcCtD
Lithium—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000724	0.00137	CcSEcCtD
Lithium—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000723	0.00137	CcSEcCtD
Lithium—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000721	0.00137	CcSEcCtD
Lithium—GSK3A—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000721	0.0054	CbGpPWpGaD
Lithium—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000719	0.00136	CcSEcCtD
Lithium—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000718	0.00136	CcSEcCtD
Lithium—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000715	0.00136	CcSEcCtD
Lithium—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000713	0.00135	CcSEcCtD
Lithium—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000709	0.00134	CcSEcCtD
Lithium—GSK3B—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.000709	0.00531	CbGpPWpGaD
Lithium—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000709	0.00134	CcSEcCtD
Lithium—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000709	0.00134	CcSEcCtD
Lithium—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000708	0.00134	CcSEcCtD
Lithium—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000707	0.00134	CcSEcCtD
Lithium—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000703	0.00133	CcSEcCtD
Lithium—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000702	0.00133	CcSEcCtD
Lithium—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000699	0.00133	CcSEcCtD
Lithium—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000699	0.00133	CcSEcCtD
Lithium—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000699	0.00132	CcSEcCtD
Lithium—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000696	0.00132	CcSEcCtD
Lithium—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000696	0.00132	CcSEcCtD
Lithium—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000695	0.00132	CcSEcCtD
Lithium—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000695	0.00132	CcSEcCtD
Lithium—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000694	0.00132	CcSEcCtD
Lithium—GSK3A—Disease—CCNT1—acquired immunodeficiency syndrome	0.000694	0.00519	CbGpPWpGaD
Lithium—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000694	0.00131	CcSEcCtD
Lithium—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000691	0.00131	CcSEcCtD
Lithium—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000691	0.00131	CcSEcCtD
Lithium—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000688	0.0013	CcSEcCtD
Lithium—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000686	0.0013	CcSEcCtD
Lithium—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000684	0.0013	CcSEcCtD
Lithium—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000682	0.00129	CcSEcCtD
Lithium—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00068	0.00129	CcSEcCtD
Lithium—GSK3B—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000679	0.00508	CbGpPWpGaD
Lithium—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000678	0.00128	CcSEcCtD
Lithium—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000678	0.00128	CcSEcCtD
Lithium—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000677	0.00128	CcSEcCtD
Lithium—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000676	0.00128	CcSEcCtD
Lithium—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000675	0.00128	CcSEcCtD
Lithium—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000675	0.00128	CcSEcCtD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.000675	0.00505	CbGpPWpGaD
Lithium—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000673	0.00128	CcSEcCtD
Lithium—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000673	0.00127	CcSEcCtD
Lithium—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00067	0.00127	CcSEcCtD
Lithium—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00067	0.00127	CcSEcCtD
Lithium—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00067	0.00127	CcSEcCtD
Lithium—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000668	0.00126	CcSEcCtD
Lithium—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000665	0.00126	CcSEcCtD
Lithium—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000664	0.00126	CcSEcCtD
Lithium—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000663	0.00126	CcSEcCtD
Lithium—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000662	0.00125	CcSEcCtD
Lithium—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000661	0.00125	CcSEcCtD
Lithium—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00066	0.00125	CcSEcCtD
Lithium—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000659	0.00125	CcSEcCtD
Lithium—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000656	0.00124	CcSEcCtD
Lithium—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000655	0.00124	CcSEcCtD
Lithium—GSK3A—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000652	0.00488	CbGpPWpGaD
Lithium—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000651	0.00123	CcSEcCtD
Lithium—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000651	0.00123	CcSEcCtD
Lithium—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00065	0.00123	CcSEcCtD
Lithium—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00065	0.00123	CcSEcCtD
Lithium—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000649	0.00123	CcSEcCtD
Lithium—GSK3A—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000649	0.00486	CbGpPWpGaD
Lithium—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000647	0.00123	CcSEcCtD
Lithium—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000647	0.00123	CcSEcCtD
Lithium—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000644	0.00122	CcSEcCtD
Lithium—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000644	0.00122	CcSEcCtD
Lithium—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000643	0.00122	CcSEcCtD
Lithium—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000643	0.00122	CcSEcCtD
Lithium—Rash—Stavudine—acquired immunodeficiency syndrome	0.000642	0.00122	CcSEcCtD
Lithium—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000641	0.00122	CcSEcCtD
Lithium—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000641	0.00122	CcSEcCtD
Lithium—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000641	0.00121	CcSEcCtD
Lithium—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00064	0.00121	CcSEcCtD
Lithium—Headache—Stavudine—acquired immunodeficiency syndrome	0.000638	0.00121	CcSEcCtD
Lithium—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000638	0.00121	CcSEcCtD
Lithium—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000637	0.00121	CcSEcCtD
Lithium—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000636	0.0012	CcSEcCtD
Lithium—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000635	0.0012	CcSEcCtD
Lithium—Rash—Abacavir—acquired immunodeficiency syndrome	0.000632	0.0012	CcSEcCtD
Lithium—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000632	0.0012	CcSEcCtD
Lithium—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000632	0.0012	CcSEcCtD
Lithium—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000631	0.0012	CcSEcCtD
Lithium—Headache—Abacavir—acquired immunodeficiency syndrome	0.000628	0.00119	CcSEcCtD
Lithium—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000627	0.00119	CcSEcCtD
Lithium—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000626	0.00119	CcSEcCtD
Lithium—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000621	0.00118	CcSEcCtD
Lithium—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000619	0.00117	CcSEcCtD
Lithium—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000615	0.00116	CcSEcCtD
Lithium—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000615	0.00116	CcSEcCtD
Lithium—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000613	0.00116	CcSEcCtD
Lithium—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000611	0.00116	CcSEcCtD
Lithium—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000608	0.00115	CcSEcCtD
Lithium—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000606	0.00115	CcSEcCtD
Lithium—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000605	0.00115	CcSEcCtD
Lithium—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000605	0.00115	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000605	0.00453	CbGpPWpGaD
Lithium—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000605	0.00115	CcSEcCtD
Lithium—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000603	0.00114	CcSEcCtD
Lithium—GSK3B—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000603	0.00451	CbGpPWpGaD
Lithium—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000602	0.00114	CcSEcCtD
Lithium—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000598	0.00113	CcSEcCtD
Lithium—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000596	0.00113	CcSEcCtD
Lithium—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000593	0.00112	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000593	0.00444	CbGpPWpGaD
Lithium—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00059	0.00112	CcSEcCtD
Lithium—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00059	0.00112	CcSEcCtD
Lithium—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000589	0.00112	CcSEcCtD
Lithium—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000588	0.00111	CcSEcCtD
Lithium—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000588	0.00111	CcSEcCtD
Lithium—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000585	0.00111	CcSEcCtD
Lithium—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000583	0.0011	CcSEcCtD
Lithium—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000575	0.00109	CcSEcCtD
Lithium—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000575	0.00109	CcSEcCtD
Lithium—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000571	0.00108	CcSEcCtD
Lithium—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000567	0.00107	CcSEcCtD
Lithium—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000563	0.00107	CcSEcCtD
Lithium—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000563	0.00107	CcSEcCtD
Lithium—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000562	0.00107	CcSEcCtD
Lithium—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000561	0.00106	CcSEcCtD
Lithium—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000558	0.00106	CcSEcCtD
Lithium—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000558	0.00106	CcSEcCtD
Lithium—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000557	0.00106	CcSEcCtD
Lithium—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000556	0.00105	CcSEcCtD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	0.000555	0.00416	CbGpPWpGaD
Lithium—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000554	0.00105	CcSEcCtD
Lithium—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000549	0.00104	CcSEcCtD
Lithium—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000546	0.00103	CcSEcCtD
Lithium—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000545	0.00103	CcSEcCtD
Lithium—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000544	0.00103	CcSEcCtD
Lithium—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000544	0.00103	CcSEcCtD
Lithium—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000544	0.00103	CcSEcCtD
Lithium—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000541	0.00103	CcSEcCtD
Lithium—GSK3A—Immune System—MBL2—acquired immunodeficiency syndrome	0.000536	0.00401	CbGpPWpGaD
Lithium—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000534	0.00101	CcSEcCtD
Lithium—GSK3B—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000533	0.00399	CbGpPWpGaD
Lithium—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000532	0.00101	CcSEcCtD
Lithium—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000526	0.000996	CcSEcCtD
Lithium—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000523	0.000992	CcSEcCtD
Lithium—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000523	0.000992	CcSEcCtD
Lithium—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000523	0.000991	CcSEcCtD
Lithium—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00052	0.000986	CcSEcCtD
Lithium—Rash—Indinavir—acquired immunodeficiency syndrome	0.000519	0.000983	CcSEcCtD
Lithium—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000518	0.000982	CcSEcCtD
Lithium—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000516	0.000979	CcSEcCtD
Lithium—Headache—Indinavir—acquired immunodeficiency syndrome	0.000515	0.000977	CcSEcCtD
Lithium—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000514	0.000974	CcSEcCtD
Lithium—GSK3B—Disease—CCNT1—acquired immunodeficiency syndrome	0.000513	0.00384	CbGpPWpGaD
Lithium—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000509	0.000964	CcSEcCtD
Lithium—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000499	0.000946	CcSEcCtD
Lithium—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000499	0.000946	CcSEcCtD
Lithium—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000494	0.000937	CcSEcCtD
Lithium—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000493	0.000935	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000493	0.00369	CbGpPWpGaD
Lithium—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000492	0.000932	CcSEcCtD
Lithium—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00049	0.000929	CcSEcCtD
Lithium—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00049	0.000928	CcSEcCtD
Lithium—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000489	0.000926	CcSEcCtD
Lithium—GSK3A—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000489	0.00366	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000488	0.00365	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.000487	0.00365	CbGpPWpGaD
Lithium—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000487	0.000923	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000486	0.00364	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000486	0.00364	CbGpPWpGaD
Lithium—GSK3B—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000482	0.0036	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.00048	0.00359	CbGpPWpGaD
Lithium—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000475	0.0009	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000473	0.00354	CbGpPWpGaD
Lithium—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000473	0.000896	CcSEcCtD
Lithium—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000471	0.000892	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000469	0.00351	CbGpPWpGaD
Lithium—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000469	0.000889	CcSEcCtD
Lithium—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000469	0.000888	CcSEcCtD
Lithium—GSK3A—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000466	0.00349	CbGpPWpGaD
Lithium—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000466	0.000883	CcSEcCtD
Lithium—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000462	0.000875	CcSEcCtD
Lithium—GSK3A—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000459	0.00343	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	0.000456	0.00341	CbGpPWpGaD
Lithium—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000455	0.000862	CcSEcCtD
Lithium—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000453	0.000859	CcSEcCtD
Lithium—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000453	0.000858	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000447	0.00335	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ALB—acquired immunodeficiency syndrome	0.000444	0.00333	CbGpPWpGaD
Lithium—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000442	0.000837	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000439	0.00329	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000438	0.00328	CbGpPWpGaD
Lithium—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000438	0.00083	CcSEcCtD
Lithium—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000437	0.000829	CcSEcCtD
Lithium—GSK3A—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000436	0.00326	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000434	0.00325	CbGpPWpGaD
Lithium—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000434	0.000822	CcSEcCtD
Lithium—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000433	0.000821	CcSEcCtD
Lithium—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000432	0.000819	CcSEcCtD
Lithium—GSK3A—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000432	0.00323	CbGpPWpGaD
Lithium—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.000817	CcSEcCtD
Lithium—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000421	0.000798	CcSEcCtD
Lithium—GSK3A—Immune System—CCR2—acquired immunodeficiency syndrome	0.00042	0.00314	CbGpPWpGaD
Lithium—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000418	0.000791	CcSEcCtD
Lithium—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.000791	CcSEcCtD
Lithium—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.00079	CcSEcCtD
Lithium—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.000786	CcSEcCtD
Lithium—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000409	0.000774	CcSEcCtD
Lithium—GSK3A—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000406	0.00304	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000406	0.00304	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000406	0.00304	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000402	0.00301	CbGpPWpGaD
Lithium—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000402	0.000761	CcSEcCtD
Lithium—GSK3A—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000399	0.00299	CbGpPWpGaD
Lithium—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000398	0.000755	CcSEcCtD
Lithium—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000398	0.000754	CcSEcCtD
Lithium—GSK3A—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000397	0.00297	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000396	0.00296	CbGpPWpGaD
Lithium—GSK3B—Immune System—MBL2—acquired immunodeficiency syndrome	0.000396	0.00296	CbGpPWpGaD
Lithium—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.00075	CcSEcCtD
Lithium—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000393	0.000745	CcSEcCtD
Lithium—GSK3A—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000378	0.00283	CbGpPWpGaD
Lithium—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000375	0.000711	CcSEcCtD
Lithium—GSK3A—Immune System—CD79A—acquired immunodeficiency syndrome	0.000367	0.00275	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000365	0.00273	CbGpPWpGaD
Lithium—GSK3A—Disease—CXCR4—acquired immunodeficiency syndrome	0.000365	0.00273	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000361	0.0027	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.00036	0.0027	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.00036	0.00269	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.00036	0.00269	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000359	0.00269	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000359	0.00269	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000347	0.00259	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000344	0.00258	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000339	0.00254	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000325	0.00243	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000324	0.00242	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000322	0.00241	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000321	0.0024	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000319	0.00239	CbGpPWpGaD
Lithium—GSK3B—Immune System—CCR2—acquired immunodeficiency syndrome	0.00031	0.00232	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.0003	0.00225	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.0003	0.00225	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.0003	0.00225	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.0003	0.00225	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000299	0.00224	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000297	0.00223	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD8A—acquired immunodeficiency syndrome	0.000296	0.00221	CbGpPWpGaD
Lithium—GSK3A—Immune System—CSF2—acquired immunodeficiency syndrome	0.000296	0.00221	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000295	0.00221	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000293	0.0022	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000292	0.00218	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000285	0.00213	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.00028	0.0021	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000279	0.00209	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000277	0.00207	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000271	0.00203	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD79A—acquired immunodeficiency syndrome	0.000271	0.00203	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000271	0.00203	CbGpPWpGaD
Lithium—GSK3B—Disease—CXCR4—acquired immunodeficiency syndrome	0.000269	0.00202	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000266	0.00199	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000255	0.00191	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000255	0.00191	CbGpPWpGaD
Lithium—GSK3A—Disease—CCR5—acquired immunodeficiency syndrome	0.00025	0.00187	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000222	0.00166	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000221	0.00165	CbGpPWpGaD
Lithium—GSK3B—Immune System—CSF2—acquired immunodeficiency syndrome	0.000219	0.00164	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD8A—acquired immunodeficiency syndrome	0.000219	0.00164	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	0.000218	0.00163	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000216	0.00161	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-B—acquired immunodeficiency syndrome	0.00021	0.00157	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000207	0.00155	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000204	0.00153	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000201	0.0015	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000194	0.00145	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000191	0.00143	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000189	0.00141	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000189	0.00141	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—acquired immunodeficiency syndrome	0.000185	0.00138	CbGpPWpGaD
Lithium—GSK3B—Disease—CCR5—acquired immunodeficiency syndrome	0.000185	0.00138	CbGpPWpGaD
Lithium—GSK3A—Immune System—IFNG—acquired immunodeficiency syndrome	0.000176	0.00132	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000175	0.00131	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD4—acquired immunodeficiency syndrome	0.00017	0.00127	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—acquired immunodeficiency syndrome	0.000164	0.00122	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—acquired immunodeficiency syndrome	0.000158	0.00118	CbGpPWpGaD
Lithium—GSK3A—Disease—CD4—acquired immunodeficiency syndrome	0.000157	0.00117	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL2—acquired immunodeficiency syndrome	0.000156	0.00117	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000144	0.00107	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000141	0.00106	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—acquired immunodeficiency syndrome	0.000132	0.000988	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNG—acquired immunodeficiency syndrome	0.00013	0.000973	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000129	0.000968	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD4—acquired immunodeficiency syndrome	0.000126	0.00094	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—acquired immunodeficiency syndrome	0.000117	0.000873	CbGpPWpGaD
Lithium—GSK3B—Disease—CD4—acquired immunodeficiency syndrome	0.000116	0.000868	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL2—acquired immunodeficiency syndrome	0.000116	0.000865	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000101	0.000757	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—acquired immunodeficiency syndrome	9.19e-05	0.000688	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—acquired immunodeficiency syndrome	8.48e-05	0.000635	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.47e-05	0.000559	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—acquired immunodeficiency syndrome	6.79e-05	0.000508	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—acquired immunodeficiency syndrome	6.27e-05	0.000469	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.94e-05	0.000445	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.39e-05	0.000329	CbGpPWpGaD
